8/10/2026 2:02:36 PM The Edges of Mayne Pharma explored By Brian Cordery Melissa Dix This article was originally published by Kluwer Patent Blog. An important aspect of the English common law system is the ability of...
8/7/2026 1:38:54 PM “Disrupting Bio Innovation”: exploring key themes in the life sciences sector at ON Helix 2026 By Jamie May Erik Müürsepp One Nucleus convened this year’s ON Helix event at the Babraham Research Campus in Cambridge, attended by Bristows’ Jamie May and Erik...
7/30/2026 4:21:16 PM The AI Act’s next big deadline is here By Charlie Hawes Vik Khurana Tom Sharpe On 2 August 2026, the EU AI Act reaches its general date of application - the point at which most of its provisions take effect and...
7/29/2026 3:55:23 PM New MHRA guidance on regulation of Ambient Voice Technology (AI Scribes) By Jamie Hatzel The MHRA today released new guidance (AVT Guidance) on Ambient Voice Technology (AVT) products and the circumstances in which these do...
7/27/2026 1:08:00 PM BIOSECURE Act for UK and EU life sciences companies: navigating China–US contracting risks By James Johnston Claire Smith The global biotech market is moving along two conflicting paths. On the one hand, Western pharmaceutical companies are seeking new...
7/17/2026 9:24:10 AM Say what you like about the competition! No fines for Sanofi in EC disparagement case By Sean-Paul Brankin On 26 June, the European Commission (EC) announced the opening of a competition law investigation into allegations of a campaign of...
7/2/2026 2:31:35 PM Bristows successfully defends provisional measures application at the UPC Court of Appeal By Liz Cohen Naoise Gaffney Rachael Cartwright Eden Winlow Florence Plisner Hannah Rigby Fariha Chowdhury Megan Lockie +5 more... Show less We are proud to report our successful defence for SOPHiA GENETICS of a PI application brought by Guardant Health Inc in the UPC Court of...
6/25/2026 3:49:11 PM A bitter pill: Court of Appeal restores CMA’s Phenytoin excessive pricing decision By Edwin Bond Iva Gobac On 19 June 2026, the Court of Appeal (CoA) issued its judgment in Pfizer/Flynn v CMA, drawing a line under the long-running UK phenytoin...
6/5/2026 4:57:37 PM Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court By Amy Howlett On 4 June 2026, the US Supreme Court handed down its judgment in Hikma Pharmaceuticals v Amarin Pharma, finding that Amarin Pharma...
6/5/2026 9:49:34 AM Life Sciences disputes: navigating causation and damages in an uncertain world By Francion Brooks As part of London International Disputes Week 2026, Bristows and Oxera hosted a discussion on causation, counterfactuals and damages in...
6/1/2026 10:47:53 AM UK venture capital: a market rebounding? By Jamie May Despite a backdrop of persistent geopolitical uncertainty, the UK venture capital (VC) space has entered a period of renewed growth and...
6/1/2026 8:39:40 AM Testing Italy’s patience: Biogen investigated over alleged abuse in MS treatment market By Edwin Bond Antonia Kendrick The Italian Competition Authority (ICA) has launched an investigation into whether Biogen has used its blockbuster multiple sclerosis...